Jafron Biomedical Co.,Ltd. (SHE:300529)
China
· Delayed Price · Currency is CNY 21.32
-0.08 (-0.37%)
Jun 27, 2025, 2:45 PM CST
Jafron Biomedical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 16,169 | 22,720 | 17,755 | 24,741 | 42,653 | 54,196 | Upgrade
| |
Market Cap Growth | 13.83% | 27.96% | -28.23% | -41.99% | -21.30% | 80.19% | Upgrade
|
Enterprise Value | 14,991 | 21,627 | 16,803 | 23,822 | 41,394 | 52,930 | Upgrade
|
Last Close Price | 20.88 | 28.29 | 21.13 | 28.75 | 48.52 | 61.31 | Upgrade
|
PE Ratio | 22.52 | 27.70 | 40.68 | 27.81 | 35.64 | 61.92 | Upgrade
|
Forward PE | 16.75 | 20.91 | 20.46 | 14.20 | 31.28 | 53.74 | Upgrade
|
PS Ratio | 6.52 | 8.49 | 9.24 | 9.93 | 15.94 | 27.78 | Upgrade
|
PB Ratio | 4.58 | 6.81 | 5.63 | 6.89 | 12.61 | 19.13 | Upgrade
|
P/TBV Ratio | 4.72 | 7.04 | 5.85 | 7.20 | 13.27 | 20.28 | Upgrade
|
P/FCF Ratio | 26.03 | 27.85 | 26.52 | 60.65 | 59.91 | 90.27 | Upgrade
|
P/OCF Ratio | 19.89 | 21.62 | 19.37 | 27.99 | 34.14 | 56.60 | Upgrade
|
EV/Sales Ratio | 6.04 | 8.08 | 8.74 | 9.56 | 15.47 | 27.13 | Upgrade
|
EV/EBITDA Ratio | 14.75 | 19.32 | 29.30 | 23.92 | 30.15 | 52.81 | Upgrade
|
EV/EBIT Ratio | 16.97 | 21.67 | 34.79 | 25.71 | 31.27 | 54.82 | Upgrade
|
EV/FCF Ratio | 24.13 | 26.51 | 25.10 | 58.40 | 58.14 | 88.16 | Upgrade
|
Debt / Equity Ratio | 0.40 | 0.42 | 0.53 | 0.36 | 0.27 | - | Upgrade
|
Debt / EBITDA Ratio | 1.39 | 1.23 | 2.90 | 1.28 | 0.67 | - | Upgrade
|
Debt / FCF Ratio | 2.27 | 1.70 | 2.50 | 3.13 | 1.29 | - | Upgrade
|
Asset Turnover | 0.43 | 0.49 | 0.35 | 0.49 | 0.67 | 0.68 | Upgrade
|
Inventory Turnover | 1.40 | 1.44 | 1.07 | 1.61 | 2.54 | 2.70 | Upgrade
|
Quick Ratio | 3.42 | 3.10 | 3.49 | 3.91 | 7.21 | 5.44 | Upgrade
|
Current Ratio | 3.94 | 3.63 | 3.99 | 4.59 | 7.91 | 6.01 | Upgrade
|
Return on Equity (ROE) | 21.24% | 25.10% | 12.63% | 25.26% | 38.47% | 34.89% | Upgrade
|
Return on Assets (ROA) | 9.57% | 11.42% | 5.51% | 11.33% | 20.61% | 21.13% | Upgrade
|
Return on Capital (ROIC) | 11.07% | 13.06% | 6.23% | 12.63% | 23.19% | 24.12% | Upgrade
|
Return on Capital Employed (ROCE) | 18.00% | 21.60% | 10.20% | 19.70% | 29.90% | 33.50% | Upgrade
|
Earnings Yield | 4.48% | 3.61% | 2.46% | 3.60% | 2.81% | 1.62% | Upgrade
|
FCF Yield | 3.84% | 3.59% | 3.77% | 1.65% | 1.67% | 1.11% | Upgrade
|
Dividend Yield | 3.78% | 2.83% | 1.89% | 2.33% | 1.85% | 1.08% | Upgrade
|
Payout Ratio | 46.39% | 41.47% | 128.71% | 82.00% | 44.37% | 43.17% | Upgrade
|
Buyback Yield / Dilution | 1.94% | 1.57% | 0.08% | 1.12% | 0.89% | -2.22% | Upgrade
|
Total Shareholder Return | 5.70% | 4.40% | 1.97% | 3.45% | 2.74% | -1.14% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.